ERV31包膜蛋白抗体

Quantity size:

0.2ml

Concentration:

1mg/ml ERV31包膜蛋白抗体  Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.

Background:

Retroviral envelope proteins mediate receptor recognition and membrane fusion during early infection. Endogenous envelope proteins may have kept, lost or modified their original function during evolution. This endogenous envelope protein has lost its fusogenic properties. It ERV31包膜蛋白抗体can inhibit cell growth through decrease expression of cyclin B1 and increased expression of p21 in vitro. SU mediates receptor recognition.
ERV31包膜蛋白抗体TM anchors the envelope heterodimer to the viral membrane through one transmembrane domain. The other hydrophobic domain, called fusion peptide, mediates fusion of the viral membrane with the target cell membrane.

ERV31包膜蛋白抗体Also known as:

Endogenous retroviral sequence 3; Endogenous retrovirus group 3 member 1; ENR1_HUMAN; Envelope polyprotein; envR; ERV R; ERV-3 envelope protein; ERV-R envelope protein; ERV3 1 envelope protein; ERV3; ERV3 envelope protein; ERV3-1; ERVR; FLJ23884; HERV R; HERV-R envelope protein; HERV-R_7q21.2 provirus ancestral Env polyprotein; HERVR; SU; TM; Transmembrane protein.

Specificity:

●

Rabbit Polyclonal IgG, affinity purified by Protein A.

●

Reacts with: Human, .

●

Immunogen: KLH conjugated synthetic peptide derived from human ERV31.

●

Predicted Molecular Weight: 68kDa.

ERV31包膜蛋白抗体Storage:

Shipped at 4℃, Store at -20℃ (Avoid repeated freeze/thaw cycles).

Application:

WB=1:100-500  ELISA=1:500-1000  IHC-P=1:100-500  IHC-F=1:100-500  ICC=1:100-500  IF=1:100-500   
Not yet tested in other applications. 
Optimal working dilutions must be determined by the end user.

kl134Mu01肿瘤坏死因子β(TNFβ)多克隆抗体Polyclonal Antibody to Tumor Necrosis Factor Beta (TNFb)

kl134Po01肿瘤坏死因子β(TNFβ)多克隆抗体Polyclonal Antibody to Tumor Necrosis Factor Beta (TNFb)

kl134Ra01肿瘤坏死因子β(TNFβ)多克隆抗体Polyclonal Antibody to Tumor Necrosis Factor Beta (TNFb)

kl134Rb51肿瘤坏死因子β(TNFβ)多克隆抗体Polyclonal Antibody to Tumor Necrosis Factor Beta (TNFb)

kl134Si01肿瘤坏死因子β(TNFβ)多克隆抗体Polyclonal Antibody to Tumor Necrosis Factor Beta (TNFb)

kl135Bo01血小板生成素(TPO)多克隆抗体Polyclonal Antibody to Thrombopoietin (TPO)

kl135Ca01血小板生成素(TPO)多克隆抗体Polyclonal Antibody to Thrombopoietin (TPO)

kl135Ga01血小板生成素(TPO)多克隆抗体Polyclonal Antibody to Thrombopoietin (TPO)

kl135Hu01血小板生成素(TPO)多克隆抗体Polyclonal Antibody to Thrombopoietin (TPO)

kl135Mu01血小板生成素(TPO)多克隆抗体Polyclonal Antibody to Thrombopoietin (TPO)

kl135Po01血小板生成素(TPO)多克隆抗体Polyclonal Antibody to Thrombopoietin (TPO)

kl135Ra01血小板生成素(TPO)多克隆抗体Polyclonal Antibody to Thrombopoietin (TPO)

kl139Ca01肿瘤坏死因子相关凋亡诱导配体(TRAIL)多克隆抗体Polyclonal Antibody to Tumor Necrosis Factor Related Apoptosis Inducing Ligand (TRAIL)

kl139Hu01肿瘤坏死因子相关凋亡诱导配体(TRAIL)多克隆抗体Polyclonal Antibody to Tumor Necrosis Factor Related Apoptosis Inducing Ligand (TRAIL)

kl139Mu01肿瘤坏死因子相关凋亡诱导配体(TRAIL)多克隆抗体Polyclonal Antibody to Tumor Necrosis Factor Related Apoptosis Inducing Ligand (TRAIL)

kl139Ra01肿瘤坏死因子相关凋亡诱导配体(TRAIL)多克隆抗体Polyclonal Antibody to Tumor Necrosis Factor Related Apoptosis Inducing Ligand (TRAIL)

kl140Bo01尿激酶型纤溶酶原激活因子(uPA)多克隆抗体Polyclonal Antibody to Plasminogen Activator, Urokinase (uPA)

kl140Ga01尿激酶型纤溶酶原激活因子(uPA)多克隆抗体Polyclonal Antibody to Plasminogen Activator, Urokinase (uPA)

kl140Hu01尿激酶型纤溶酶原激活因子(uPA)多克隆抗体Polyclonal Antibody to Plasminogen Activator, Urokinase (uPA)

kl140Mu01尿激酶型纤溶酶原激活因子(uPA)多克隆抗体Polyclonal Antibody to Plasminogen Activator, Urokinase (uPA)

kl140Po01尿激酶型纤溶酶原激活因子(uPA)多克隆抗体Polyclonal Antibody to Plasminogen Activator, Urokinase (uPA)

kl140Ra01尿激酶型纤溶酶原激活因子(uPA)多克隆抗体Polyclonal Antibody to Plasminogen Activator, Urokinase (uPA)

kl140Rb51尿激酶型纤溶酶原激活因子(uPA)多克隆抗体Polyclonal Antibody to Plasminogen Activator, Urokinase (uPA)